Medications in this category include benazepril (Lotensin), captopril (Capoten) and enalapril (Vasotec).
这类药物包括贝那普利(洛汀新)、卡托普利(开博通)、依那普利等。
Objective To observe the therapeutic effect and safety of niaoduqing particles combined with lotensin on renal hypertension (RH).
目的观察尿毒清颗粒联合洛汀新治疗肾性高血压的疗效和安全性。
Objective: to explore the effect and safety of Lotensin in the treatment of childrens renal proteinuria and its relation to ACE gene.
目的：探讨洛丁新治疗小儿肾性蛋白尿的效果、安全性以及与ace基因多态性的相互关系。
Conclusion Nniaoduqing particles combined with lotensin was efficient and safe for the treatment of RH, which was more efficient than lotensin alone.
结论尿毒清颗粒联合洛汀新治疗肾性高血压安全有效，其疗效优于单独使用洛汀新。
Method: Determination of essential hypertension group and normal control group the concentration of CRP level lotensin oral group after 12 weeks of the change in plasma CRP concentration.
方法：分别测定高血压病组和正常对照组crp的浓度水平，洛汀新口服12周后两组的血浆CRP浓度变化。
Method: Determination of essential hypertension group and normal control group the concentration of CRP level lotensin oral group after 12 weeks of the change in plasma CRP concentration.
方法：分别测定高血压病组和正常对照组crp的浓度水平，洛汀新口服12周后两组的血浆CRP浓度变化。
应用推荐